Clinical trial
Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion
NCT05477147 is registered in ClinicalTrials.gov with Volta Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion
- Lead sponsor
- Volta Medical
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 17, 2023
- Completion date
- September 30, 2025
- Enrollment
- 96 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.